SVP and Chief Technical Officer Michael J. Labarre sold $365K of Halozyme Therapeutics, Inc.

Sold$365,148

$30.43Price

12,000Shares

−8%Stake

What HALO did after the filing

Prices for HALO after this filing aren't in yet.

Traded Tue, Oct 20. Filed Tue, Oct 20, 12:53 PM ET, during the session. Not investment advice.